GSK is Exploring a Once a Month Injectable HIV Treatment Regimen
Pharmacokinetics, Safety and Tolerability of the HIV Integrase Inhibitor S/GSK1265744 Long Acting Parenteral Nanosuspension Following Single Dose Administration to Healthy Adults Presented at the International AIDS Conference in Washington this week Discussion — S/GSK1265744 long acting parenteral administration prolonged plasma levels (apparent t1/2of 2150days; Figure 4) compared with oral administration (oral …
GSK is Exploring a Once a Month Injectable HIV Treatment Regimen Read More »